Ipilimumab生物仿制药是一种重组人单克隆抗体，可与细胞毒性T淋巴细胞相关抗原4（CTLA-4）结合。Ipilimumab生物仿制药是一种IgG 1 κ免疫球蛋白，分子量约为148 kDa。伊匹单抗生物仿制药在哺乳动物（中国仓鼠卵巢）细胞培养物中生产。 Ipilimumab生物仿制药-研究级该产品同种型对照：Bulk Human IgG1 Isotype Control (IB1) [ICH2254] 缓冲液：ICH3001-100ml，nICH3002-100ml，nICH3003-100ml， 浓度：1.0 - 5.0 mg/ml 纯度：>95% by SDS-PAGE and HPLC 内毒素：≤ 1.0 EU/mg as determined by the LAL method 制剂：Phosphate buffered saline (PBS) pH 7.2,with no carrier protein, potassium or preservatives added. BSA and Azide free.
